Search Results - "Schaaf, Cecilia R"

  • Showing 1 - 16 results of 16
Refine Results
  1. 1
  2. 2

    Culture of equine intestinal epithelial stem cells after delayed tissue storage for future applications by Stewart, Amy Stieler, Schaaf, Cecilia R, Veerasammy, Brittany, Freund, John M, Gonzalez, Liara M

    Published in BMC veterinary research (23-12-2022)
    “…Equine intestinal epithelial stem cells (ISCs) serve as potential targets to treat horses with severe intestinal injury. The ability to isolate and store ISCs…”
    Get full text
    Journal Article
  3. 3

    Use of Translational, Genetically Modified Porcine Models to Ultimately Improve Intestinal Disease Treatment by Schaaf, Cecilia R, Gonzalez, Liara M

    Published in Frontiers in veterinary science (20-05-2022)
    “…For both human and veterinary patients, non-infectious intestinal disease is a major cause of morbidity and mortality. To improve treatment of intestinal…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Enhancing the Efficacy of HIPEC Through Bromelain: A Preclinical Investigation in Appendiceal Cancer by Wajih, Nadeem, Erali, Richard A., Forsythe, Steven D., Schaaf, Cecilia R., Shen, Perry, Levine, Edward A., Soker, Shay, Morris, David L., Votanopoulos, Konstantinos I.

    Published in Annals of surgical oncology (01-08-2024)
    “…Introduction Appendiceal cancer (AC) excessive mucin production is a barrier to heated intraperitoneal chemotherapy (HIPEC) drug delivery. Bromelain is a…”
    Get full text
    Journal Article
  6. 6

    A LGR5 reporter pig model closely resembles human intestine for improved study of stem cells in disease by Schaaf, Cecilia R., Polkoff, Kathryn M., Carter, Amber, Stewart, Amy S., Sheahan, Breanna, Freund, John, Ginzel, Joshua, Snyder, Joshua C., Roper, Jatin, Piedrahita, Jorge A., Gonzalez, Liara M.

    Published in The FASEB journal (01-06-2023)
    “…Intestinal epithelial stem cells (ISCs) are responsible for intestinal epithelial barrier renewal; thereby, ISCs play a critical role in intestinal…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9

    In Vitro Three-Dimensional (3D) Models for Melanoma Immunotherapy by Nomdedeu-Sancho, Gemma, Gorkun, Anastasiya, Mahajan, Naresh, Willson, Kelsey, Schaaf, Cecilia R, Votanopoulos, Konstantinos I, Atala, Anthony, Soker, Shay

    Published in Cancers (01-12-2023)
    “…Melanoma is responsible for the majority of skin cancer-related fatalities. Immune checkpoint inhibitor (ICI) treatments have revolutionized the management of…”
    Get full text
    Journal Article
  10. 10

    Utilizing Patient-Derived Organoids in the Management of Colorectal Cancer with Peritoneal Metastases: A Review of Current Literature by Erali, Richard A., Forsythe, Steven D., Gironda, Daniel J., Schaaf, Cecilia R., Wajih, Nadeem, Soker, Shay, Votanopoulos, Konstantinos I.

    Published in Journal of gastrointestinal cancer (01-09-2023)
    “…Introduction Treatment of colorectal cancer-derived peritoneal carcinomatosis (CRC-PC) is challenging due to cellular heterogeneity that exhibits variable…”
    Get full text
    Journal Article
  11. 11

    Changes in equine intestinal stem/progenitor cell number at resection margins in cases of small intestinal strangulation by Veerasammy, Brittany, Gonzalez, Gabriel, Báez-Ramos, Patricia, Schaaf, Cecilia R, Stewart, Amy Stieler, Ludwig, Elsa K, McKinney-Aguirre, Caroline, Freund, John, Robertson, James, Gonzalez, Liara M

    Published in Equine veterinary journal (01-11-2023)
    “…Intestinal epithelial stem cells (ISC) are responsible for epithelial regeneration and are critical to the intestine's ability to regain barrier function…”
    Get full text
    Journal Article
  12. 12

    Immune-reactive tumor organoids system to determine the effects of microbial metabolites on cancer immunity and immunotherapies by El-Derby, Azza M., Schaaf, Cecilia R., Shelkey, Ethan, Cook, Katherine L., Votanopoulos, Konstantinos I., Soker, Shay

    Published in Frontiers in microbiomes (07-10-2024)
    “…Immunotherapies are a revolutionary approach to treating cancer by utilizing the body’s immune system to target and combat cancer cells. This approach offers…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15
  16. 16